Palivizumab epitope–displaying virus-like particles protect rodents from RSV challenge - Schickli, Jeanne H.; Whitacre, David C.; Tang, Roderick S.; Kaur, Jasmine; Lawlor, Heather; Peters, Cory J.; Jones, Joyce E.; Peterson, Darrell L.; McCarthy, Michael P.; Van Nest, Gary; Milich, David R. (The Journal of clinical investigation, 2015)
Keywords: Animals; Antibodies, Monoclonal, Humanized - immunology; Antibodies, Viral - biosynthesis; Antibodies, Viral - immunology; Antibody Specificity; Antigenic determinants; Antigens, Viral - immunology; Binding sites; Biomedical research; Combinatorial Chemistry Techniques; Cryoelectron Microscopy; Enzyme-Linked Immunosorbent Assay; Gene therapy; Health aspects; Helix-Loop-Helix Motifs - immunology; Hepadnavirus; Hepatitis B Virus, Woodchuck - genetics; Humans; Immunodominant Epitopes - immunology; Immunoglobulin G - biosynthesis; Immunoglobulin G - immunology; Innovations; Mice; Mice, Inbred BALB C; Palivizumab; Prevention; Protein Conformation; Proteins; Recombinant Fusion Proteins - chemistry; Recombinant Fusion Proteins - immunology; Respiratory syncytial virus; Respiratory Syncytial Virus Infections - prevention & control; Respiratory Syncytial Viruses - immunology; Sigmodontinae; Software; Technical Advance; Vaccination; Vaccines; Vaccines, Virus-Like Particle; Viral Fusion Proteins - chemistry; Viral Fusion Proteins - immunology; Viral Vaccines - immunology